EE371 Treatment Patterns, Healthcare Resource Use, and Costs Among US Patients With Epidermal Growth Factor Receptor Mutated (EGFRm) Metastatic Non-Small Cell Lung Cancer (mNSCLC) After Discontinuation of Osimertinib
Abstract
Authors
L. Moore-Schiltz D McMorrow J Chambers Z Pulungan C Teigland L Marrett